HDAC6 Links B-ALL Motility to Relapse
A July 26 British Journal of Cancer study linked elevated HDAC6 expression with relapse in pediatric and adult B-ALL cohorts and showed that pharmacologic inhibition or shRNA depletion reduced CXCL12-driven actin remodeling, endothelial migration,…
